T1	Intervention 584 619	received arzoxifene 20 or 50 mg/day
T2	Intervention 691 799	Toxicities were graded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) system.
T3	Intervention 800 897	Pharmacokinetic data were analyzed using the NONMEM software program (GloboMax, Hanover, MD, USA)
T4	Intervention 621 689	Tumor response was assessed using World Health Organization criteria
